Your browser doesn't support javascript.
loading
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache, Ioana; Beltran, Jessica; Akdis, Cezmi; Akdis, Mubeccel; Canelo-Aybar, Carlos; Canonica, Giorgio Walter; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; Del Giacco, Stefano; Eiwegger, Thomas; Firinu, Davide; Gern, James E; Hamelmann, Eckard; Hanania, Nicola; Mäkelä, Mika; Hernández-Martín, Irene; Nair, Parameswaran; O'Mahony, Liam; Papadopoulos, Nikolaos G; Papi, Alberto; Park, Hae-Sim; Pérez de Llano, Luis; Posso, Margarita; Rocha, Claudio; Quirce, Santiago; Sastre, Joaquin; Shamji, Mohamed; Song, Yang; Steiner, Corinna; Schwarze, Jurgen; Alonso-Coello, Pablo; Palomares, Oscar; Jutel, Marek.
Afiliação
  • Agache I; Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Beltran J; Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Akdis C; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Akdis M; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
  • Canelo-Aybar C; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Canonica GW; Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Casale T; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Chivato T; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
  • Corren J; Division of Allergy and Immunology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Del Giacco S; School of Medicine, University CEU San Pablo, Madrid, Spain.
  • Eiwegger T; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Firinu D; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Gern JE; Translational Medicine Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
  • Hamelmann E; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Hanania N; Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Hospital for Sick Children, Departments of Paediatrics and Immunology, University of Toronto, Toronto, Canada.
  • Mäkelä M; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Hernández-Martín I; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Nair P; Klinik für Kinder- und Jugendmedizin Kinderzentrum Bethel, Bielefeld, Germany.
  • O'Mahony L; Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Papadopoulos NG; Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Papi A; Department of Allergy, Hospital Universitario La Paz, Madrid, Spain.
  • Park HS; Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Pérez de Llano L; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada.
  • Posso M; Departments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
  • Rocha C; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Quirce S; Allergy Department, Second Pediatric Clinic, National Kapodistrian University of Athens, Athens, Greece.
  • Sastre J; Research Center on Asthma and COPD, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Shamji M; Department of Allergy and Clinical Immunology, Ajou University, Suwon, Korea.
  • Song Y; Department of Respiratory Medicine, Hospital Lucus Augusti, Lugo, Spain.
  • Steiner C; Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Schwarze J; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Alonso-Coello P; Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Palomares O; Department of Allergy, La Paz University Hospital, IdiPAZ, CIBER of Respiratory Diseases (CIBERES), Universidad Autónoma de Madrid, Madrid, Spain.
  • Jutel M; Universidad Autónoma de Madrid Facultad de Medicina, Madrid, Spain.
Allergy ; 75(5): 1023-1042, 2020 05.
Article em En | MEDLINE | ID: mdl-32034960
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Produtos Biológicos / Antiasmáticos Tipo de estudo: Guideline / Systematic_reviews Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Revista: Allergy Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Romênia País de publicação: Dinamarca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Produtos Biológicos / Antiasmáticos Tipo de estudo: Guideline / Systematic_reviews Aspecto: Patient_preference Limite: Adolescent / Adult / Aged / Child / Humans / Middle aged Idioma: En Revista: Allergy Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Romênia País de publicação: Dinamarca